Nahid Amini - Concepedia

Author

Nahid Amini

Karolinska Institutet

Also Known As

Nahid Amini, Nahid Amini (742999), Nahid Ghaed Amini

Publications

965

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet AstraZeneca (Sweden)Stockholm County Council Takeda (Japan)Karolinska University Hospital

About

Nahid Amini is an author at Karolinska Institutet specializing in medicine, pharmacology, and positron emission tomography.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	250
2	Engineering	4	4	146
3	Health Sciences	4	4	102
4	Social Sciences	2	2	26
5	Natural Sciences	1	1	80

Nahid Amini

Publications

914

Citations

H-Index

Page 1

	Year	Citations
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease Aurelija Jučaitė, Per Svenningsson, Juha O. Rinne, Brain	2015	219
In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, <sup>18</sup>F-Labeled Deuterated Fluorodeprenyl Sangram Nag, Patrik Fazio, Lutz Lehmann, Journal of Nuclear Medicine	2015	82
Palladium‐Mediated [<sup>11</sup>C]Carbonylation at Atmospheric Pressure: A General Method Using Xantphos as Supporting Ligand Kenneth Dahl, Magnus Schou, Nahid Amini, European Journal of Organic Chemistry Inorganic ChemistryChemical EngineeringAryl HalidesEngineeringCross-coupling Reaction	2013	80
Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain Sjoerd J. Finnema, Anders Ettrup, Ryuji Nakao, NeuroImage Agonist Pet RadioligandFunctional SelectivityMedicineReceptor (Biochemistry)5-Ht2c Receptors	2013	73
Quantitative Analysis of <sup>18</sup>F-(<i>E</i>)-<i>N</i>-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4′-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease Patrik Fazio, Per Svenningsson, Anton Forsberg, Journal of Nuclear Medicine	2015	57
Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates Magnus Schou, Katarina Varnäs, Stefan Lundquist, The International Journal of Neuropsychopharmacology	2015	44
Sample preparation techniques for radiometabolite analysis of positron emission tomography radioligands; trends, progress, limitations and future prospects Mohammad Mahdi Moein, Ryuji Nakao, Nahid Amini, TrAC Trends in Analytical Chemistry Positron Emission TomographySample Preparation TechniquesEngineeringMedical ImagingRadioactive Contamination	2018	43
In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects Marielle Delnomdedieu, Anton Forsberg, Adam Ogden, Neuropharmacology Positron Emission TomographyMedicinePet-mriBioanalysisPde10a Enzyme Occupancy	2017	36
A human [ 11 C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor Akihiro Takano, Per Stenkrona, Nahid Amini, NeuroImage Pde10a BindingMedicinePde10a InhibitorImmunologyClinical Pharmacology	2016	30
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D 2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18 F-MNI-659 and 11 C-raclopride with correction for partial volume effect Patrik Fazio, Martin Schain, Ladislav Mrzljak, NeuroImage PsychiatryNeuroanatomyMedicineNeuropharmacologyNeurology	2017	28

Page 1